Impact of Concomitant Medication Use and Immune-Related Adverse Events on Response to Immune Checkpoint Inhibitors is a research paper published in Immunotherapy (2020). On theSindex it has a DataRank of 0. It has been cited 33 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30CA016056
National Institutes of Health
Grant: P01 CA206980
National Institutes of Health
Grant: R01 CA205246
National Institutes of Health
Grant: 3P01CA206980-02S2
Genomic Evaluation of the Female Survival Advantages in Melanoma
Alkermes
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5P30CA016056-40
Roswell Park Cancer Institute Cancer Center Support Grant
National Institutes of Health
Grant: 5R01CA205246-03
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitors
Alkermes
Iovance
BMS and Merck
Merrimack
Athenex and Roswell Park Alliance Foundation
EMD Soreno
Merck
FWCI
3.27
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals